Myelodysplastic-Myeloproliferative Diseases
"Myelodysplastic-Myeloproliferative Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clonal myeloid disorders that possess both dysplastic and proliferative features but are not properly classified as either MYELODYSPLASTIC SYNDROMES or MYELOPROLIFERATIVE DISORDERS.
| Descriptor ID |
D054437
|
| MeSH Number(s) |
C15.378.190.615
|
| Concept/Terms |
Myelodysplastic-Myeloproliferative Diseases- Myelodysplastic-Myeloproliferative Diseases
- Disease, Myelodysplastic-Myeloproliferative
- Diseases, Myelodysplastic-Myeloproliferative
- Myelodysplastic Myeloproliferative Diseases
- Myelodysplastic-Myeloproliferative Disease
- Myeloproliferative-Myelodisplastic Diseases
- Disease, Myeloproliferative-Myelodisplastic
- Diseases, Myeloproliferative-Myelodisplastic
- Myeloproliferative Myelodisplastic Diseases
- Myeloproliferative-Myelodisplastic Disease
|
Below are MeSH descriptors whose meaning is more general than "Myelodysplastic-Myeloproliferative Diseases".
Below are MeSH descriptors whose meaning is more specific than "Myelodysplastic-Myeloproliferative Diseases".
This graph shows the total number of publications written about "Myelodysplastic-Myeloproliferative Diseases" by people in this website by year, and whether "Myelodysplastic-Myeloproliferative Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myelodysplastic-Myeloproliferative Diseases" by people in Profiles.
-
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee. Bone Marrow Transplant. 2026 May; 61(5):591-600.
-
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Blood. 2014 Apr 24; 123(17):2645-51.
-
Myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN, U): natural history and clinical outcome by treatment strategy. Leukemia. 2014 Apr; 28(4):958-61.
-
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Blood. 2011 Dec 08; 118(24):6239-46.
-
Trisomy 14 as a sole chromosome abnormality is associated with older age, a heterogenous group of myeloid neoplasms with dysplasia, and a wide spectrum of disease progression. J Biomed Biotechnol. 2010; 2010:365318.